Vestibular schwannomas (VSs) are benign neoplasms that arise from Schwann cells at the neuroglial-neurilemmal junction (Obersteiner-Redlich's zone)
Introduction
Vestibular schwannomas (VSs) are benign neoplasms that arise from Schwann cells at the neuroglial-neurilemmal junction (Obersteiner-Redlich's zone) 1 of either the inferior 2,3 or superior vestibular nerve. 4 They comprise 8 to 10% of all intracranial tumors and more than 80% of cerebellopontine angle tumors. 5 VS usually presents with tinnitus, hearing loss, and/or disequilibrium; however, large tumors may also present with facial hypoesthesia, facial nerve (FN) weakness, lower cranial nerve dysfunction, ataxia, or hydrocephalus. 5 Incidences of postoperative FN weakness as well as FN preservation after VS treatment have been thoroughly discussed in the literature. However, facial weakness as a
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Abstract
Background and Study Aim Facial nerve (FN) weakness as a presenting feature in vestibular schwannoma (VS) is extremely rare. We are presenting two different cases of VS with significant facial weakness and reviewed the literature for similar cases.
Methods and Results
We are presenting two cases of VS with significant facial weakness. The first case was a 63-year-old male patient presented with 3 weeks' history of severe left-sided facial weakness (House-Brackmann [HB] grade V) and hearing loss. Magnetic resonance imaging (MRI) of the brain showed a tumor in the left internal auditory canal. Gross total removal with anatomical and physiological FN preservation was performed through a retrosigmoid approach under neurophysiological monitoring. FN function improved postoperatively to HB grade II after 16 months. The other case was 83-year-old male patient presented with sudden left-sided hearing loss and severe facial weakness (HB grade V). MRI of the brain 2.5 years before showed a leftsided (Class-T3A) cystic VS. The tumor was asymptomatic; wait-and-scan strategy was advised by the treating neurologist. Recent MRI of the brain showed approximately three times enlargement of the tumor with brain stem compression, extensive cystic changes, and suspected intratumoral hemorrhage. Surgery was performed; the tumor was subtotally removed through a retrosigmoid approach with intraoperative FN monitoring. The FN was anatomically preserved; however, physiological preservation was not possible. Severe facial weakness with incomplete lid closure persisted postoperatively. Conclusion Surgical treatment could be offered to cases of suspected VS presenting with facial weakness, as these cases may still have a chance for improvement especially in laterally located tumors.
presenting feature in VS is rarely discussed. Only 4 to 8% of VS patients presents with facial weakness. [6] [7] [8] The optimal surgical management of these cases is a challenge to the surgeons. We are presenting two different cases of VS with significant facial weakness, and we reviewed the literature for similar cases.
Case 1
A diabetic 63-year-old male patient presented with 3 weeks' history of severe left-sided facial weakness. Two years ago, the patient had a similar attack of facial weakness on the right side that improved after corticosteroid therapy. Neurological examination revealed in addition to severe left-sided facial palsy (House-Brackmann [HB] grade V), hearing loss on the left side. Cerebrospinal fluid examination showed no manifestation of inflammatory process. Magnetic resonance imaging (MRI) of the brain showed a tumor in the left internal auditory canal (IAC) with slight extrameatal extension and no extension into the fallopian canal (►Fig. 1). The lesion was isointense in T1, slightly hyperintense in T2-weighted images, with homogenous enhancement after contrast injection. Because of the previous history of contralateral Bell's palsy, the patient was initially treated with corticosteroids. After failed improvement of the facial weakness under corticosteroids for 3 weeks, surgical removal of the tumor was offered to the patient. Gross total tumor removal was performed through a retrosigmoid approach with intraoperative neurophysiological monitoring. Intraoperatively, the FN could be stimulated with a good response from both orbicularis oculi and orbicularis oris following bipolar stimulation starting at 0.1 mAmp.
The tumor was involving the vestibular division of the eighth cranial nerve and was extrinsic to the FN. Facial and cochlear nerves were anatomically preserved during surgery. At the end of surgery, FN stimulation at the exit zone from the brain stem was effective at 0.1 mAmp. The pathological examination revealed schwannoma of Antoni-A category with significant fibrotic and regressive changes. The last follow-up examination (after 16 months) showed improvement of the FN function to HB grade II, and cranial imaging using MRI of the brain with and without contrast showed no evidence of tumor remnant or recurrence (►Fig. 1).
Case 2
A 83-year-old male patient presented with sudden left-sided hearing loss and facial weakness (HB grade V). MRI of the brain 2.5 years earlier showed a left-sided (Class-T3A) cystic VS. The tumor was asymptomatic; wait-and-scan strategy was advised by the treating neurologist. Recent MRI of the brain showed approximately three times enlargement of the tumor (Class-T4A) with brain stem compression, extensive cystic changes, and suspected intratumoral hemorrhage (►Fig. 2). The patient was taking antiplatelet drug (aspirin and clopidogrel) due to recent coronary stents. After holding aspirin and clopidogrel for 5 days, surgery was performed within 3 weeks of the onset of facial weakness; the tumor was subtotally removed through a retrosigmoid approach with intraoperative FN monitoring.
The tumor was cystic with areas of old bleeding and the FN was extremely stretched anterosuperior to the tumor. To preserve the integrity of the FN, a small part of the tumor was left at its entrance into the IAC. Intraoperative FN stimulation with up to 1 mAmp gave a very week response so that functional preservation was not sure. Pathological examination revealed Antoni-A schwannoma with signs of old and fresh intratumoral bleeding as well as regressive changes. Severe facial weakness (HB grade V) with incomplete lid closure persisted postoperative, and tarsorrhaphy was performed to avoid corneal ulceration. MRI of the brain with contrast was performed 6 months postoperatively and showed tumor remnant at the IAC (►Fig. 2). The clinical examination after 6 months revealed severe facial weakness so that hypoglossofacial anastomosis was offered to the patient.
Discussion
Facial weakness is reported as a rare presentation in cases of VS, and usually occurs with large tumors especially those undergoing rapid expansion or cystic degeneration.
9
Matthies and Samii reviewed the presenting symptoms of 1,000 VS and found facial weakness in 6% of the cases. 7 Wiegand et al reviewed 62 cases of intracanalicular VS, of whom 2 (3.2%) had presented with facial weakness. 10 Therefore, significant facial weakness in the setting of a cerebellopontine tumor should raise the suspicion for a tumor rather than VS, like FN schwannoma, 11,12 meningioma, 9,13 or other less common pathologies as malignancy or cavernous hemangioma.
14-16
Important factors that influence the management of facial weakness include the duration and severity of weakness as well as the nature of the underlying pathology. 17 Patients with FN schwannomas usually present with facial weakness either in the form of sudden paralysis or recurrent attacks of facial palsy with recovery in between the attacks. 18 Extension of FN schwannomas beyond the fundus of the IAC and involvement of other segments of the intratemporal FN are diagnostic in most cases. 11, 19 There are previous reports of cases of FN schwannomas not extending into fallopian canal and associated with normal FN function, and these cases were suspected to be VSs and discovered to be FN schwannomas during surgery. 20, 21 In cases of FN schwannomas involving the IAC and associated with severe facial weakness, surgery may be considered and FN reanimation is usually included. 22 The mechanism of FN weakness in cases of VS is usually due to direct compression 17 rather than infiltrative growth as in cases of FN schwannoma; 13 therefore, anatomical preservation of the FN could be possible during surgical removal of these tumors. The other factor that could influence facial function recovery after surgery is the timing of intervention. [23] [24] [25] [26] Several reports showed that surgical treatment within 3 months of facial paralysis in cases of benign temporal bone lesions is associated with significant recovery of function. 17, 26 Our first patient was suspected to have Bell's palsy due to previous history of facial weakness on the contralateral side; however, the patient did not show any improvement under corticosteroids for 3 weeks. In this case, the tumor was intracanalicular with no involvement of other segments of the intratemporal FN, and total tumor removal was possible with anatomical and physiological FN preservation, and the facial function improved postoperative to HB grade II.
Reviewing the literature, we found five cases of intracanalicular VS presented with significant facial weakness. The authors described five patients presented with 1 to 3 months' history of moderate or severe facial weakness (HB grades III-V) in the setting of small intracanalicular VSs, the tumors were removed with significant postoperative improvement of facial function 3 months after surgery. 6, 17, 27 Translabyrinthine approach was performed in three cases, 6,17 whereas in two cases, 27 the authors used the retrosigmoid approach. The tumors were totally removed in four cases; however, in one case, near-total removal was performed. The authors reported anatomical preservation of the FN in all cases, interestingly intraoperative stimulation of the proximal part of the FN was possible in spite of significant facial weakness. The same in our first patient, tumor was totally removed and stimulation of the proximal part of the FN with 0.1 mAmp associated with good response, the facial function improved postoperative to HB grade II. We agree with other authors 17,27 that anatomical preservation of the FN should be the aim during removal of these tumors even at the expense of total tumor removal. The mechanism of facial weakness in these cases is unclear, as previously mentioned direct compression of the nerve may be a possible explanation, edema and/or ischemia of the FN fibers may result from compression of the nerve against the borders of the internal auditory meatus.
27
Although the FN is frequently crushed against the borders of the internal auditory meatus in cases of VS, FN weakness is extremely rare; therefore, other possible mechanisms such as inflammation should be considered.
Our second case represents a different scenario; a case of cystic VS that showed progress in size with signs of intratumoral hemorrhage (ITH) and resulted in sudden facial weakness in an old patient who took antiplatelet drugs due to recent cardiac stents. Sudden deterioration of symptoms in a case of cystic VS is usually due to ITH. 
36
Surgery for cystic VS represents a challenge due to extreme adhesions with the FN. Piccirillo et al observed unfavorable FN outcome in cases of medially located thinwalled cysts. 37 Xia et al studied the outcome predictors in cases of cystic VS, and they divided them according to the presence of fluid-fluid level into two groups. They found more peritumoral adhesions in the fluid-fluid level group; in addition, this group has worse outcome regarding rate of total tumor removal and FN preservation. They concluded that repeated ITH with subsequent inflammatory reaction resulted in destruction in the tumor-nerve barrier and consequently difficult dissection. 38 In addition, the FN is extremely thinned and stretched over the tumor in these cases, and this makes anatomical preservation extremely difficult. In cases of acute tumor expansion with acute presenting symptoms such as facial weakness, the condition is more difficult. Severe facial weakness in these cases is usually a result of significant damage of the nerve. In our second case although direct FN stimulation resulted in a weak response, we preferred to leave a small part of the tumor at the FN entry to the IAC to preserve the anatomical integrity of the nerve; nevertheless, the facial function did not improve postoperative. Therefore, we could recommend total tumor removal with FN reanimation (using sural nerve graft) if the nerve could not be stimulated intraoperatively.
Conclusion
We discussed two cases of VS presenting with severe facial weakness. The cases represent different scenarios, one case of small tumor that compressed the FN near the IAC and the facial weakness improved after surgery. The other case represented a sudden deterioration due to hemorrhage in a cystic VS, with no improvement of facial function after subtotal tumor removal. Surgical treatment could be offered to cases of suspected VS presenting with facial weakness, as these cases may still have a chance for improvement especially in laterally located tumors. Intraoperative FN monitoring is very important in these cases, if the nerve is still stimulated proximally, functional recovery usually occurs. In cases where proximal FN stimulation was ineffective, complete tumor removal followed by FN reanimation should be performed.
